Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Expenses
Research and development	$ 4,131,978	$ 5,520,928	$ 9,091,841	$ 8,779,635
General and administrative	2,833,211	3,442,365	5,862,606	7,691,179
Total expenses	6,965,189	8,963,293	14,954,447	16,470,814
Loss from operations	(6,965,189)	(8,963,293)	(14,954,447)	(16,470,814)
Foreign exchange gains (losses)	1,596	(18,997)	(2,198)	(23,853)
Investment income	72,378	4,566	79,795	8,666
Non-cash interest expense for the sale of future royalties	(1,826,499)	(1,611,439)	(3,605,293)	(2,907,895)
Net loss	$ (8,717,714)	$ (10,589,163)	$ (18,482,143)	$ (19,393,896)
Net loss per share, basic and diluted	$ (1.63)	$ (1.98)	$ (3.46)	$ (3.63)
Weighted average shares outstanding, basic and diluted	5,340,196	5,340,196	5,340,196	5,340,196